Back to results
US 10,189,910 B2Granted
Anti-DPEP3 antibodies and methods of use
AssigneeAbbvie Stemcentrx LLC
InventorsLaura Saunders, Deepti Rokkam, David Liu, Mandy Boontanrart
Life of this patent
Estimating the term…
Abstract
Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
Claims38
An antibody drug conjugate comprising a monoclonal antibody conjugated, linked, or otherwise associated with a cytotoxic agent,
- wherein the monoclonal antibody binds human DPEP3 and comprises three complementarity determining regions of a light chain variable region set forth as SEQ ID NO:
- 205 and three complementarity determining regions of a heavy chain variable region set forth as SEQ ID NO:
- 207.
Dependencies are inferred from the claim text.